Vertex Pharmaceuticals

Industry group: Drugs

Headquarters: Massachusetts

Overview

Average pay of disclosed executives at Vertex Pharmaceuticals

Annual data

2018

On April 26, 2019, Vertex Pharmaceuticals reported executive compensation for fiscal year 2018.

NamePositionCompensationDetails
Jeffrey M. LeidenChairman, President & CEO$18,799,147
Stuart A. ArbuckleEVP & Chief Commercial Officer$5,347,092
Michael PariniEVP & Chief Legal and Administrative Officer$5,372,336
Amit SachdevEVP & Chief Regulatory Officer$5,678,261
Jeffrey ChodakewitzFormer EVP & Chief Medical Officer$5,696,996
Thomas GraneyFormer SVP & Chief Financial Officer$2,937,685
Ian F. SmithFormer EVP & Chief Operating and Interim Chief Financial Officer$4,626,134

Jeffrey M. Leiden — Chairman, President & CEO — received the highest compensation: $18,799,147 in total.

In addition, Jeffrey Chodakewitz — Former EVP & Chief Medical Officer — received a total compensation of $5,696,996; Amit Sachdev received $5,678,261; Michael Parini received $5,372,336; Stuart A. Arbuckle received $5,347,092; Ian F. Smith received $4,626,134; Thomas Graney received $2,937,685.

The company's median employee pay was $232,178.

2017

NamePositionCompensationDetails
Stuart A. ArbuckleEVP & Chief Commercial Officer$4,400,633
Jeffrey M. LeidenChairman, President & CEO$17,227,301
David AltshulerEVP & Chief Scientific Officer$5,730,427
Thomas GraneySVP & Chief Financial Officer$1,927,400
Michael PariniEVP & Chief Legal and Administrative Officer$5,978,620
Amit SachdevEVP & Chief Regulatory Officer$4,886,263
Ian F. SmithEVP & Chief Operating Officer$5,936,236

Jeffrey M. Leiden — Chairman, President & CEO — received the highest compensation: $17,227,301 in total.

In addition, Michael Parini — EVP & Chief Legal and Administrative Officer — received a total compensation of $5,978,620; Ian F. Smith received $5,936,236; David Altshuler received $5,730,427; Amit Sachdev received $4,886,263; Stuart A. Arbuckle received $4,400,633; Thomas Graney received $1,927,400.

2016

On April 28, 2017, Vertex Pharmaceuticals reported executive compensation for fiscal year 2016.

NamePositionCompensationDetails
Jeffrey M. LeidenChairman, President & CEO$17,419,758
Ian F. SmithEVP & Chief Operating Officer and CFO$5,780,677
David AltshulerEVP & Chief Scientific Officer$4,787,349
Stuart A. ArbuckleEVP & Chief Commercial Officer$5,561,062
Michael PariniEVP & Chief Legal and Administrative Officer$7,730,264
Amit SachdevEVP & Chief Regulatory Officer$5,435,009

Jeffrey M. Leiden — Chairman, President & CEO — received the highest compensation: $17,419,758 in total.

In addition, Michael Parini — EVP & Chief Legal and Administrative Officer — received a total compensation of $7,730,264; Ian F. Smith received $5,780,677; Stuart A. Arbuckle received $5,561,062; Amit Sachdev received $5,435,009; David Altshuler received $4,787,349.

2015

On April 29, 2016, Vertex Pharmaceuticals reported executive compensation for fiscal year 2015.

NamePositionCompensationDetails
Jeffrey ChodakewitzEVP & Chief Medical Officer$7,830,416
Jeffrey M. LeidenChairman, President & CEO$28,099,826
Ian F. SmithEVP & Chief Operating Officer and CFO$9,005,983
David AltshulerEVP & Chief Scientific Officer$12,387,868
Stuart A. ArbuckleEVP & Chief Commercial Officer$8,822,449

Jeffrey M. Leiden — Chairman, President & CEO — received the highest compensation: $28,099,826 in total.

In addition, David Altshuler — EVP & Chief Scientific Officer — received a total compensation of $12,387,868; Ian F. Smith received $9,005,983; Stuart A. Arbuckle received $8,822,449; Jeffrey Chodakewitz received $7,830,416.

2014

NamePositionCompensationDetails
Jeffrey ChodakewitzEVP & Chief Medical Officer$13,796,092
Kenneth L. HortonFormer EVP & Chief Legal Officer$9,907,133
Jeffrey M. LeidenChairman, President & CEO$36,635,468
Ian F. SmithEVP & Chief Operating Officer and CFO$15,303,863
Stuart A. ArbuckleEVP & Chief Commercial Officer$15,197,613

Jeffrey M. Leiden — Chairman, President & CEO — received the highest compensation: $36,635,468 in total.

In addition, Ian F. Smith — EVP & Chief Operating Officer and CFO — received a total compensation of $15,303,863; Stuart A. Arbuckle received $15,197,613; Jeffrey Chodakewitz received $13,796,092; Kenneth L. Horton received $9,907,133.

2013

NamePositionCompensationDetails
Jeffrey M. LeidenChairman, President & CEO$13,126,474
Ian F. SmithEVP & Chief Financial Officer$4,184,762
Stuart A. ArbuckleEVP & Chief Commercial Officer$4,819,022
Peter MuellerEVP, Global R&D Chief Scientific Officer$4,176,149
Kenneth L. HortonFormer EVP & Chief Legal Officer$4,539,551

Jeffrey M. Leiden — Chairman, President & CEO — received the highest compensation: $13,126,474 in total.

In addition, Stuart A. Arbuckle — EVP & Chief Commercial Officer — received a total compensation of $4,819,022; Kenneth L. Horton received $4,539,551; Ian F. Smith received $4,184,762; Peter Mueller received $4,176,149.

2012

NamePositionCompensationDetails
Peter MuellerEVP, Global R&D Chief Scientific Officer$3,614,890
Jeffrey M. LeidenChairman, President & CEO$5,656,684
Ian F. SmithEVP & Chief Financial Officer$3,109,193
Stuart A. ArbuckleEVP & Chief Commercial Officer$4,808,697
Kenneth L. HortonFormer EVP & Chief Legal Officer$2,802,735
Matthew W. EmmensFormer Chairman, President CEO$6,896,029
David T. Howton, JrFormer SVP & Chief Legal Officer$3,447,898

Matthew W. Emmens — Former Chairman, President CEO — received the highest compensation: $6,896,029 in total.

In addition, Jeffrey M. Leiden — Chairman, President & CEO — received a total compensation of $5,656,684; Stuart A. Arbuckle received $4,808,697; Peter Mueller received $3,614,890; David T. Howton, Jr received $3,447,898; Ian F. Smith received $3,109,193; Kenneth L. Horton received $2,802,735.

2011

NamePositionCompensationDetails
Jeffrey M. LeidenChairman, President & CEO$10,717,661
Ian F. SmithEVP & Chief Financial Officer$3,344,580
Peter MuellerEVP, Global R&D Chief Scientific Officer$3,937,612
Nancy J. WysenskiEVP & Chief Commercial Officer$3,352,768
Matthew W. EmmensFormer Chairman, President CEO$13,358,534

Matthew W. Emmens — Former Chairman, President CEO — received the highest compensation: $13,358,534 in total.

In addition, Jeffrey M. Leiden — Chairman, President & CEO — received a total compensation of $10,717,661; Peter Mueller received $3,937,612; Nancy J. Wysenski received $3,352,768; Ian F. Smith received $3,344,580.

2010

On April 8, 2011, Vertex Pharmaceuticals reported executive compensation for fiscal year 2010.

NamePositionCompensationDetails
Kenneth S. BogerSenior Vice President and Chief Legal Officer$2,607,267
Amit SachdevSenior Vice President, Corporate Affairs and Public Policy, and Commercial Business Lead, Canada$2,503,161
Nancy J. WysenskiEVP & Chief Commercial Officer$1,547,282
Ian F. SmithEVP & Chief Financial Officer$3,122,481
Peter MuellerEVP, Global R&D Chief Scientific Officer$3,699,927
Matthew W. EmmensFormer Chairman, President CEO$14,912,160

Matthew W. Emmens — Former Chairman, President CEO — received the highest compensation: $14,912,160 in total.

In addition, Peter Mueller — EVP, Global R&D Chief Scientific Officer — received a total compensation of $3,699,927; Ian F. Smith received $3,122,481; Kenneth S. Boger received $2,607,267; Amit Sachdev received $2,503,161; Nancy J. Wysenski received $1,547,282.

2009

NamePositionCompensationDetails
Kenneth S. BogerSenior Vice President and Chief Legal Officer$3,161,083
Amit SachdevSenior Vice President, Corporate Affairs and Public Policy, and Commercial Business Lead, Canada$4,029,657
Matthew W. EmmensChair, President CEO$19,278,158
Ian F. SmithEVP & Chief Financial Officer$9,104,036
Peter MuellerEVP, Global Research and Development, & Chief Scientific Officer$9,254,586
Nancy J. WysenskiEVP & Chief Commercial Officer$10,178,214
Joshua BogerFormer President and Chief Executive Officer$10,148,369

Matthew W. Emmens — Chair, President CEO — received the highest compensation: $19,278,158 in total.

In addition, Nancy J. Wysenski — EVP & Chief Commercial Officer — received a total compensation of $10,178,214; Joshua Boger received $10,148,369; Peter Mueller received $9,254,586; Ian F. Smith received $9,104,036; Amit Sachdev received $4,029,657; Kenneth S. Boger received $3,161,083.

2008

NamePositionCompensationDetails
Ian F. SmithExecutive Vice President and Chief Financial Officer$2,262,326
Peter MuellerExecutive Vice President, Global Research and Development, and Chief Scientific Officer$2,974,464
Kenneth S. BogerSenior Vice President and Chief Legal Officer$1,915,470
Kurt C. GravesExecutive Vice President, Chief Commercial Officer and Head, Strategic Development$2,073,457
Joshua BogerFormer President and Chief Executive Officer$6,304,485

Joshua Boger — Former President and Chief Executive Officer — received the highest compensation: $6,304,485 in total.

In addition, Peter Mueller — Executive Vice President, Global Research and Development, and Chief Scientific Officer — received a total compensation of $2,974,464; Ian F. Smith received $2,262,326; Kurt C. Graves received $2,073,457; Kenneth S. Boger received $1,915,470.

2007

NamePositionCompensationDetails
Kurt C. GravesExecutive Vice President, Chief Commercial Officer and Head, Strategic Development$1,285,890
Kenneth S. BogerSenior Vice President and General Counsel$2,111,174
Ian F. SmithExecutive Vice President and Chief Financial Officer$3,372,273
Peter MuellerExecutive Vice President, Global Research and Development, and Chief Scientific Officer$3,493,105
Joshua BogerFormer President and Chief Executive Officer$7,720,455

Joshua Boger — Former President and Chief Executive Officer — received the highest compensation: $7,720,455 in total.

In addition, Peter Mueller — Executive Vice President, Global Research and Development, and Chief Scientific Officer — received a total compensation of $3,493,105; Ian F. Smith received $3,372,273; Kenneth S. Boger received $2,111,174; Kurt C. Graves received $1,285,890.

2006

NamePositionCompensationDetails
Joshua BogerChief Executive Officer$5,922,958
Ian F. SmithExecutive Vice President and Chief Financial Officer$1,914,697
Peter MuellerExecutive Vice President, Drug Innovation and Realization, and Chief Scientific Officer$1,982,518
Kenneth S. BogerSenior Vice President and General Counsel$1,698,103

Joshua Boger — Chief Executive Officer — received the highest compensation: $5,922,958 in total.

In addition, Peter Mueller — Executive Vice President, Drug Innovation and Realization, and Chief Scientific Officer — received a total compensation of $1,982,518; Ian F. Smith received $1,914,697; Kenneth S. Boger received $1,698,103.